Related Experiment Video

Updated: May 31, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Molecular dynamics simulation reveals structural and thermodynamic features of kinase activation by cancer mutations

Shunzhou Wan1, Peter V Coveney

  • 1Department of Chemistry, Centre for Computational Science, University College London, London WC1H 0AJ, United Kingdom.

Journal of Computational Chemistry
|July 1, 2011
PubMed

Insights

The L834R mutation in epidermal growth factor receptor (EGFR) enhances lung cancer progression by altering active and inactive forms. This study reveals how this common mutation affects EGFR kinase activation and stability.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Computational Biology

Background:

  • Epidermal growth factor receptor (EGFR) drives lung carcinoma growth and progression.
  • EGFR activation involves conformational changes between active and inactive states.
  • EGFR mutations can alter activation, drug efficacy, and promote cancer.

Purpose of the Study:

  • Investigate the enhanced activation mechanism of EGFR associated with the L834R mutation.
  • Analyze structural and energetic properties of active and inactive EGFR conformations with the L834R mutation.
  • Characterize the thermodynamic stabilities of EGFR conformations influenced by the L834R mutation.

Main Methods:

  • Extended timescale molecular dynamics (MD) simulations.
  • Analysis of structural and energetic properties of EGFR.
  • Free energy landscape calculations using molecular mechanics/Poisson-Boltzmann solvent area (MM/PBSA).

Main Results:

  • The L834R mutation induces conformational changes in both active and inactive EGFR states.
  • The mutation alters the relative thermodynamic stabilities of the active and inactive conformations.
  • These alterations contribute to the enhanced activation of the EGFR kinase.

Conclusions:

  • The L834R mutation in EGFR plays a significant role in lung cancer progression by modulating kinase activation.
  • Understanding these mutation-induced conformational changes is crucial for developing targeted therapies.
  • Computational simulations provide insights into the molecular mechanisms underlying EGFR-driven lung cancer.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: